Manufacturing supply chains are needed that can withstand disruptive shocks and safeguard health security.
Biopharmaceutical manufacturing has not kept pace with scientific advancement, preventing new discoveries from reaching patients at speed or scale.
Resilience is creating a first-of-its-kind ecosystem for advanced biopharmaceutical manufacturing. We provide a network of high-tech, end-to-end manufacturing and development solutions to ensure the medicines of today and tomorrow can be made quickly, safely, and at scale.
We continuously invest in R&D for next generation manufacturing and development, freeing our partners to focus on the discoveries that impact lives.
Resilience offers customized and scalable processes, the highest quality and regulatory capabilities, and world-class talent and facilities for complex and novel medicines. This includes cell and gene therapies, viral vectors, vaccines, proteins, and new discoveries.
Through manufacturing that’s faster, safer, and more flexible, we safeguard the quality of important medicines and protect the resilience of a vital supply chain.
Resilience offers a broad mix of customized manufacturing capabilities to serve the needs of biopharmaceutical partners at all stages of the drug development process – from pre-clinical development to commercial supply.